Publications
Japanese encephalitis
- Yakob L, Hu W, Frentiu FD, Gyawali N, Hugo LE, Johnson B, Lau C, Furuya-Kanamori L, et al. Japanese Encephalitis Emergence in Australia: The Potential Population at Risk. Clinical Infectious Diseases. 2023
- Furuya-Kanamori L, Gyawali N, Mills DJ, Mills C, Hugo LE, Devine GJ, et al. Immunogenicity of a single fractional intradermal dose of Japanese encephalitis live attenuated chimeric vaccine. Journal of Travel Medicine. 2022
- Furuya-Kanamori L, Gyawali N, Mills DJ, Hugo LE, Devine GJ, Lau CL. The Emergence of Japanese Encephalitis in Australia and the Implications for a Vaccination Strategy. Tropical Medicine and Infectious Disease. 2022
- Islam N, Lau C, Leeb A, Mills D, Furuya-Kanamori L. Safety profile comparison of chimeric live attenuated and Vero cell-derived inactivated Japanese encephalitis vaccines through an active surveillance system in Australia. Human Vaccines & Immunotherapeutics. 2022
- Islam N, Xu C, Lau CL, Mills DJ, Clark J, Devine GJ, Hugo LE, Gyawali N, Thalib L, Furuya-Kanamori L. Persistence of antibodies, boostability, and interchangeability of Japanese encephalitis vaccines: A systematic review and dose-response meta-analysis. Vaccine. 2022
- Furuya-Kanamori L, Xu C, Doi SAR, Clark J, Wangdi K, Mills DJ, et al. Comparison of immunogenicity and safety of licensed Japanese encephalitis vaccines: A systematic review and network meta-analysis. Vaccine. 2021
- Mills DJ, Lau CL, Furuya-Kanamori L. Low uptake of Japanese encephalitis vaccination among Australian travellers. Journal of Travel Medicine. 2020
- Furuya-Kanamori L, Mills DJ, Lau CL. Could intradermal be an economical alternative route of administration for Japanese encephalitis vaccines? Journal of Travel Medicine. 2020
- Jelinek T, Cromer MA, Cramer JP, Mills D et al. Safety and immunogenicity of an inactivated Vero cell_derived Japanese encephalitis vaccine (IXIARO ® , JESPECT ® ) in a pediatric population in JE non-endemic countries: An uncontrolled, open-label phase 3 study. Travel Medicine and Infectious Disease. March 2018
Rabies
Guo Y, Mills DJ, Lau CL, Mills C, Furuya‐Kanamori L. Immune response after rabies pre‐exposure prophylaxis and a booster dose in Australian bat carers. Zoonoses and Public Health. 2023 May 11;zph.13048
Mills DJ, Lau CL, Mills C, Furuya-Kanamori L. Long-term persistence of antibodies and boostability after rabies intradermal pre exposure prophylaxis. Journal of Travel Medicine. 2021
Mills DJ, Lau CL, Mills C, Furuya-Kanamori L. Efficacy of one-dose intramuscular rabies vaccine as pre-exposure prophylaxis in travellers. Journal of Travel Medicine. 2021
Ling W, Doi SAR, Lau CL, Mills DJ, Kostoulas P, Furuya-Kanamori L. Diagnostic accuracy of ELISA kits for measurement of rabies antibodies. Journal of Travel Medicine. 2021
Xu C, Lau CL, Clark J, Rafferty AC, Mills DJ, Ramsey L, et al. Immunogenicity after pre- and post-exposure rabies vaccination: A systematic review and dose-response meta-analysis. Vaccine. 2021
Furuya-Kanamori L, Ramsey L, Manson M, Gilbert B, Lau CL. Intradermal rabies pre-exposure vaccination schedules in older travellers: comparison of immunogenicity post-primary course and post-booster. Journal of Travel Medicine. 2020
Mills D. Intradermal pre-exposure rabies vaccination. Promises and pitfalls. Travel Medicine and Infectious Disease 2013
Lau CL, Hohl N. Immunogenicity of a modified intradermal pre-exposure rabies vaccination schedule using a purified chick embryo cell vaccine: An observational study. Travel Medicine and Infectious Disease. 2013
Mills DJ, Lau CL, Fearnley EJ, Weinstein P. The Immunogenicity of a Modified Intradermal Pre-exposure Rabies Vaccination Schedule – A Case Series of 420 Travelers. Journal of Travel Medicine. 2011
Mills DJ, Lau CL, Weinstein P. Animal bites and rabies exposure in Australian travellers. Medical Journal of Australia. 2011
Lau C, Sisson J. The Effectiveness of Intradermal Pre-exposure Rabies Vaccination in an Australian Travel Medicine Clinic. Journal of Travel Medicine. 2006
Antimicrobial resistance
- Furuya-Kanamori L, Mills DJ, Trembizki E, Robson JM, Jennison AV, Whiley DM, et al. High rate of asymptomatic colonization with antimicrobial-resistant Escherichia coli in Australian returned travellers. Journal of Travel Medicine. 2021
- Furuya-Kanamori L, Stone J, Yakob L, Kirk M, Collignon P, Mills DJ, et al. Risk factors for acquisition of multidrug-resistant Enterobacterales among international travellers: A synthesis of cumulative evidence. Journal of Travel Medicine. 2019
Malaria
- Islam N, Wright S, Lau CL, Doi SAR, Mills DJ, Clark J, et al. Efficacy of a 3-day pre-travel schedule of Tafenoquine for malaria chemoprophylaxis: A network meta-analysis. Journal of Travel Medicine. 2021
- Lau CL, Ramsey L, Mills L, Furuya-Kanamori L, Mills DJ. Drug-free holidays: Compliance, tolerability, and acceptability of a 3-day atovaquone/proguanil schedule for pre-travel malaria chemoprophylaxis in Australian travellers. Clinical Infectious Diseases. 2018
Gap year travellers
- Furuya-Kanamori L, Lau CL, Banks S, Mills DJ. Impact of pre-departure preparation on the health and wellbeing of Australian gap year travellers. Travel Medicine and Infectious Disease. 2020
- Furuya-Kanamori L, Mills D, Sheridan S, Lau C. Medical and psychological problems faced by young Australian gap year travellers. Journal of Travel Medicine. 2017
Hepatitis
- Furuya-Kanamori L, Dutton P, Leeb A, Mills DJ, Andrews R, Lau CL. Adverse Events Following Immunization With Combined vs Concurrent Monovalent Hepatitis A and Typhoid Vaccines in Children. Journal of the Pediatric Infectious Diseases Society. 2020
- David MC, Ha SH, Paynter S, Lau C. A systematic review and meta-analysis of management options for adults who respond poorly to hepatitis B vaccination. Vaccine. 2015
- Lau CL, Streeton CL, David MC, Sly PD, Mills DJ.The tolerability of a combined hepatitis A and typhoid vaccine in children aged 2–16 years: an observational study. Journal of Travel Medicine. 2016
Other vector borne diseases
- Lau CL, Weinstein P, Slaney D. Dengue surveillance by proxy: travellers as sentinels for outbreaks in the Pacific Islands. Epidemiology and Infection. 2013
- Flies EJ, Lau CL, Carver S, Weinstein P. Another Emerging Mosquito-Borne Disease? Endemic Ross River Virus Transmission in the Absence of Marsupial Reservoirs. BioScience. 2018
- Aubry M, Kama M, Vanhomwegen J, Teissier A, Mariteragi-Helle T, Hue S, C Lau, et al. Ross River Virus Antibody Prevalence, Fiji Islands, 2013–2015. Emerging Infectious Diseases. 2019
- Lau C, Aubry M, Musso D, Teissier A, Paulous S, Desprès P, et al. New evidence for endemic circulation of Ross River virus in the Pacific Islands and the potential for emergence. International Journal of Infectious Diseases. 2017
- Lau C, Weinstein P, Slaney D. Imported cases of Ross River virus disease in New Zealand – A travel medicine perspective. Travel Medicine and Infectious Disease. 2012
Other zoonotic diseases
- Armstrong M, Francis J, Robson J, Graves S, Mills DJ, Ferguson J, et al. Q fever vaccination of children in Australia: Limited experience to date. Journal of Paediatrics and Child Health. 2019
- Ritter JM, Lau C, Craig SB, Goarant C, Nilles EJ, Ko AI, et al. A Large Leptospirosis Outbreak following Successive Severe Floods in Fiji, 2012. The American Journal of Tropical Medicine and Hygiene. 2018
- Lau C, Smythe L, Weinstein P. Leptospirosis: An emerging disease in travellers. Travel Medicine and Infectious Disease. 2010
- Derne B, Weinstein P, Musso D, Lau C. Distribution of rickettsioses in Oceania: Past patterns and implications for the future. Acta Tropica. 2015
Other travel medicine publications
- Rafferty AC, Bofkin K, Hughes W, Souter S, Hosegood I, Hall RN, Furuya-Kanamori L, et al. Does 2×2 airplane passenger contact tracing for infectious respiratory pathogens work? A systematic review of the evidence. PLoS One. 2023
- Mills DJ, Ramsey L, Furuya-Kanamori L. Pre- and Post-Travel Medical Consultations. In: Wilks J, Pendergast D, Leggat PA, Morgan D, editors. Tourist Health, Safety and Wellbeing in the New Normal. Singapore: Springer Singapore; 2021
- Lau CL, Mayfield HJ, Sinclair JE, Brown SJ, Waller M, Enjeti AK, et al. Risk-benefit analysis of the AstraZeneca COVID-19 vaccine in Australia using a Bayesian network modelling framework. Vaccine. 2021
- Wang J, Liu-Lastres B, Ritchie BW, Mills DJ. Travellers’ self-protection against health risks: An application of the full Protection Motivation Theory. Annals of Tourism Research. 2019
- Lau CL, Sweet M, Weinstein P. A stitch in time: unrecognized retained foreign bodies after a needlefish injury. Journal of Travel Medicine. 2017
- Huang X, Lambert S, Lau C, Soares Magalhaes RJ, Marquess J, Rajmokan M, et al. Assessing the social and environmental determinants of pertussis epidemics in Queensland, Australia: a Bayesian spatio-temporal analysis. Epidemiology and Infection. 2017
- Mills, D.J.,Kohl, S.E. Twitter for travel medicine providers. Journal of Travel Medicine. 2016
- Martin-Blondel G, Iriart X, Baidouri F, Simon S, Mills D, et al. Outbreak of Leishmania braziliensis Cutaneous Leishmaniasis, Saül, French Guiana. Emerging Infectious Diseases. 2015
- Leggat PA, Mills D, Speare R. Level of Concern and Sources of Information of a Group of Brisbane Hostelers for Personal Safety and Terrorism When Traveling Abroad. Journal of Travel Medicine. 2007
- Mulhall BP, Hu M, Thompson M, Lin F, Lupton D, Mills D, Maund M, Cass R, Millar D. Planned sexual behaviour of young Australian visitors to Thailand. Medical Journal of Australia. 1993